| An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors (NCT06013111) | China Medical University, China | 2023-10-23 |
| A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants (NCT05960032) | Pfizer | 2023-10-23 |
| Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches (NCT06112093) | State University of New York - Upstate Medical University | 2023-10-23 |
| ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer (NCT05542407) | UNC Lineberger Comprehensive Cancer Center | 2023-10-23 |
| Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin (NCT06118684) | EpiEndo Pharmaceuticals | 2023-10-23 |
| Study of [14C]CS0159 in China Healthy Subjects (NCT06098027) | Cascade Pharmaceuticals, Inc | 2023-10-23 |
| Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma (NCT05921760) | Servier Bio-Innovation LLC | 2023-10-23 |
| A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2) (NCT06088017) | Chong Kun Dang Pharmaceutical | 2023-10-23 |
| Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects. (NCT06642987) | Hanlim Pharm. Co., Ltd. | 2023-10-23 |
| Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model (NCT05436444) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-10-23 |
| Phase 1 Study of KH607 Tablets (NCT06393803) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2023-10-21 |
| A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects (NCT06081465) | Zhejiang Vimgreen Pharmaceuticals, Ltd. | 2023-10-20 |
| A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma (NCT06084962) | He Huang | 2023-10-20 |
| Hydroxylated Polymethoxy Flavones Solid Dispersion in Treatment of Periodontitis (NCT05546788) | Assiut University | 2023-10-20 |
| A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or Degeneration (NCT06074783) | Cellcolabs Clinical LTD. | 2023-10-20 |
| A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma (NCT06049290) | Nanjing Leads Biolabs Co.,Ltd | 2023-10-20 |
| Functional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRI (NCT05433961) | Xemed LLC | 2023-10-20 |
| A Study of Avutometinib for People With Solid Tumor Cancers (NCT06104488) | Memorial Sloan Kettering Cancer Center | 2023-10-20 |
| Recall by Genotype: Neuropeptide Stimulation (NCT05901467) | Stephanie B. Seminara, MD | 2023-10-20 |
| A Study in Healthy Men to Test How Zongertinib is Taken up in the Body When Taken With or Without Food (NCT06075277) | Boehringer Ingelheim | 2023-10-19 |
| Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy (NCT05849467) | National Institute of Neurological Disorders and Stroke (NINDS) | 2023-10-19 |
| R-2487 in Patients With Rheumatoid Arthritis (NCT05961592) | Rise Therapeutics LLC | 2023-10-19 |
| A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1) (NCT05984147) | Aurigene Discovery Technologies Limited | 2023-10-19 |
| Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects (NCT06247748) | Beijing Dongfang Biotech Co., Ltd. | 2023-10-19 |
| A Study of BN104 in the Treatment of Acute Leukemia (NCT06052813) | Institut de Recherches Internationales Servier (I.R.I.S.) | 2023-10-19 |
| A Phase I Study of LY3502970 in Healthy Participants (NCT06085482) | Eli Lilly and Company | 2023-10-19 |
| Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413 (NCT06101927) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2023-10-19 |
| A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer (NCT06067841) | Bristol-Myers Squibb | 2023-10-18 |
| KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors (NCT06026410) | Kura Oncology, Inc. | 2023-10-18 |
| A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer (NCT05902988) | Volastra Therapeutics, Inc. | 2023-10-18 |
| DBS for Depression (NCT06096207) | Northwell Health | 2023-10-18 |
| Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers (NCT04713046) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-10-18 |
| Effects of Mulligan Technique With or Without Diclofenac Phonophoresis on Patellofemoral Pain Syndrome. (NCT06439251) | University of Lahore | 2023-10-18 |
| A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1) (NCT06041256) | Aurion Biotech | 2023-10-18 |
| Infracalcaneal Peppering Injection Technique for Chronic Plantar Fasciitis (NCT05868577) | Wake Forest University Health Sciences | 2023-10-18 |
| Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection (NCT06508138) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-10-18 |
| Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage (NCT05853601) | Medical College of Wisconsin | 2023-10-17 |
| De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC (NCT06572514) | Ruijin Hospital | 2023-10-17 |
| DZD9008 PK Study in Hepatic Impairment Subjects (NCT06084104) | Dizal Pharmaceuticals | 2023-10-17 |
| A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. (NCT05944224) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-10-17 |
| A Drug-Drug Interaction Study of Diltiazem and MK-1167 in Healthy Adult Participants (MK-1167-006) (NCT06703463) | Merck Sharp & Dohme LLC | 2023-10-17 |
| Comparative Effects of Autologous Serum, Umbilical Cord Blood-Derived Drops, and Platelet Lysate on Ocular Surface Parameters (NCT07551843) | G.Gennimatas General Hospital | 2023-10-17 |
| A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants (NCT06049095) | Latigo Biotherapeutics | 2023-10-17 |
| A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects (NCT06045624) | Ornovi, Inc. | 2023-10-17 |
| A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors (NCT05951608) | Akeso | 2023-10-16 |
| A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults (NCT05945485) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-10-16 |
| Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection (NCT06002503) | PharmaJet, Inc. | 2023-10-16 |
| A Study of Olanzapine After Intranasal and Intramuscular Administration (NCT06600477) | Neurelis, Inc. | 2023-10-16 |
| Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration (NCT05657301) | Chengdu Origen Biotechnology Co., Ltd. | 2023-10-16 |
| PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes (NCT06091267) | Otsuka Beijing Research Institute | 2023-10-16 |
| A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AB801 in Healthy Volunteers (NCT06004921) | Arcus Biosciences, Inc. | 2023-10-16 |
| A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants (NCT06006702) | Tyra Biosciences, Inc | 2023-10-16 |
| A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants (NCT06092931) | DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company | 2023-10-16 |
| K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation (NCT06127940) | Karolinska University Hospital | 2023-10-15 |
| The Application of Novel Oncolytic Virus in Late Stage Solid Tumors (NCT06080984) | West China Hospital | 2023-10-15 |
| A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor (NCT06205082) | LittDD Medicines Ltd | 2023-10-14 |
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. (NCT06022029) | OncoNano Medicine, Inc. | 2023-10-13 |
| Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution (NCT06120842) | SpyGlass Pharma, Inc. | 2023-10-13 |
| Reirradiation and Niraparib in Patients With Recurrent Glioblastoma (NCT05666349) | University College, London | 2023-10-13 |
| Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers (NCT05891171) | Arcus Biosciences, Inc. | 2023-10-13 |
| A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia (NCT06107803) | Minerva Neurosciences | 2023-10-13 |
| A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants (NCT06077786) | H. Lundbeck A/S | 2023-10-13 |
| Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer (NCT05318469) | Yuan Yuan | 2023-10-13 |
| DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia (NCT05158166) | University of California, San Francisco | 2023-10-13 |
| Assessing Impact of Early Physiotherapy on Lymphatic Dysfunction in Head and Neck Cancer Survivorship (NCT05937269) | The University of Texas Health Science Center, Houston | 2023-10-12 |
| A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome (NCT05804669) | Crinetics Pharmaceuticals Inc. | 2023-10-12 |
| Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis (NCT05961956) | Novadip Biosciences | 2023-10-12 |
| A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors (NCT06063681) | Stingray Therapeutics | 2023-10-12 |
| Exparel vs. ACB With Bupivacaine for ACL Reconstruction (NCT06274008) | Children's Hospital of Orange County | 2023-10-12 |
| A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese Ethnicity (NCT06084598) | Bristol-Myers Squibb | 2023-10-12 |
| A Study of EXG102-031 in Participants With wAMD (NCT06183814) | Guangzhou Jiayin Biotech Ltd | 2023-10-12 |
| Cryospray Therapy for Benign Airway Stenosis (NCT06085209) | Virginia Commonwealth University | 2023-10-12 |
| SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment (NCT06010953) | Hangzhou Gensciences Biopharmaceutical Co., Ltd. | 2023-10-12 |
| Repurposing Lithium for Parkinson's Disease (NCT06099886) | State University of New York at Buffalo | 2023-10-12 |
| Lithium Long COVID Dose-finding Study (NCT06108297) | State University of New York at Buffalo | 2023-10-12 |
| Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage (NCT06087965) | Tang-Du Hospital | 2023-10-11 |
| A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) . (NCT05959694) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-10-11 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants (NCT06226064) | Vesper Biotechnologies ApS | 2023-10-11 |
| Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies (NCT06052852) | Bolt Biotherapeutics, Inc. | 2023-10-11 |
| HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors (NCT05681650) | Chinese PLA General Hospital | 2023-10-11 |
| Pharmacokinetics of ZSP1273 in Elder Participants (NCT06157450) | Guangdong Raynovent Biotech Co., Ltd | 2023-10-11 |
| Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer (NCT05922930) | M.D. Anderson Cancer Center | 2023-10-11 |
| Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies (NCT05377827) | Washington University School of Medicine | 2023-10-10 |
| Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease (NCT06129409) | NodThera Limited | 2023-10-10 |
| A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies (NCT06038058) | BioRay Pharmaceutical Co., Ltd. | 2023-10-10 |
| PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors (NCT06078670) | Fujian Cancer Hospital | 2023-10-10 |
| Metabolism and Excretory of HSK21542 in Maintenance Hemodialysis Patients (NCT06238388) | Haisco Pharmaceutical Group Co., Ltd. | 2023-10-10 |
| Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane (NCT05146739) | National Cancer Institute (NCI) | 2023-10-10 |
| Combining ICI With SBRT or HypoFrx-RT for ES NSCLC (NCT05451173) | Alexander Chi | 2023-10-09 |
| Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia (NCT06080555) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2023-10-09 |
| A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer (NCT05963997) | Carrick Therapeutics Limited | 2023-10-09 |
| Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors (NCT06082960) | Gilead Sciences | 2023-10-09 |
| A Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of Telmisartan and Dapagliflozin. (NCT06063109) | THPharm Corp. | 2023-10-09 |
| An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma (NCT05980507) | The First Affiliated Hospital of Soochow University | 2023-10-09 |
| A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine (NCT06021600) | M.D. Anderson Cancer Center | 2023-10-09 |
| A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects (NCT06141577) | Korea United Pharm. Inc. | 2023-10-08 |
| The Efficacy and Safty of FMT in Patients With CID (NCT05917379) | Peking University Sixth Hospital | 2023-10-08 |
| YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis (NCT06048588) | Beijing Inno Medicine Co., Ltd. | 2023-10-08 |
| CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection (NCT06560827) | CARsgen Therapeutics Co., Ltd. | 2023-10-08 |
| Antiperistaltic Effect and Safety of Glycopyrronium for Colonoscopic Polypectomy (NCT06041984) | Jie Chen | 2023-10-08 |